Stanislav Piletsky

Mr. Stanislav Piletsky

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012
Verified
Book Chapter
Closed access
SPSergey Piletsky
Sergey Piletsky
SPStanislav Piletsky
Stanislav Piletsky
Iva ChianellaIva Chianella
Iva Chianella

28 October 2022 in Polymers
Verified
Journal Article
Open access
PDF file
SKSamr kassem
Samr kassem
SPStanislav Piletsky
Stanislav Piletsky
HYHasan Yesilkaya
Hasan Yesilkaya
OGOzcan Gazioglu
Ozcan Gazioglu
MHMedhanie Habtom
Medhanie Habtom
SPSergey Piletsky
Sergey Piletsky
Molecularly imprinted polymer nanoparticles (nanoMIPs) are high affinity synthetic receptors which show promise as imaging and therapeutic agents. Comprehensive analysis of the in vivo behaviour of nanoMIPs must be performed before they can be considered for clinical applications. This work reports the solid-phase synthesis of nanoMIPs and an investigation of their biodistribution, clearance and cytotoxicity in a rat model following both intravenous and oral administration. These nanoMIPs were found in each harvested tissue type, including brain tissue, implying their ability to cross the blood–brain barrier. The nanoMIPs were cleared from the body via both faeces and urine. Furthermore, we describe an immunogenicity study in mice, demonstrating that nanoMIPs specific for a cell surface protein showed moderate adjuvant properties, whilst those imprinted for a scrambled peptide showed no such behaviour. Given their ability to access all tissue types and their relatively low cytotoxicity, these results pave the way for in vivo applications of nanoMIPs.

7 December 2016 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
SPStanislav Piletsky
Stanislav Piletsky
SRS. Rabinowicz
S. Rabinowicz
ZYZ. Yang
Z. Yang
CZC. Zagar
C. Zagar
Elena PiletskaElena Piletska
Elena Piletska
SPStanislav Piletsky
Stanislav Piletsky
A novel system for blood type testing is developed based on the first molecularly imprinted nanoparticles specific to oligosaccharides.

14 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Elena PiletskaElena Piletska
Elena Piletska
HYHeersh Yawer
Heersh Yawer
FCFrancesco Canfarotta
Francesco Canfarotta
EMEwa Moczko
Ewa Moczko
KSKatarzyna Smolinska-Kempisty
Katarzyna Smolinska-Kempisty
SPSergey A. Piletsky
Sergey A. Piletsky
Herein we describe the preparation of molecularly imprinted silica nanoparticles by Ostwald ripening in the presence of molecular templates immobilised on glass beads (the solid-phase). To achieve this, a seed material (12 nm diameter silica nanoparticles) was incubated in phosphate buffer in the presence of the solid-phase. Phosphate ions act as a catalyst in the ripening process which is driven by differences in surface energy between particles of different size, leading to the preferential growth of larger particles. Material deposited in the vicinity of template molecules results in the formation of sol-gel molecular imprints after around 2 hours. Selective washing and elution allows the higher affinity nanoparticles to be isolated. Unlike other strategies commonly used to prepare imprinted silica nanoparticles this approach is extremely simple in nature and can be performed under physiological conditions, making it suitable for imprinting whole proteins and other biomacromolecules in their native conformations. We have demonstrated the generic nature of this method by preparing imprinted silica nanoparticles against targets of varying molecular mass (melamine, vancomycin and trypsin). Binding to the imprinted particles was demonstrated in an immunoassay (ELISA) format in buffer and complex media (milk or blood plasma) with sub-nM detection ability.

3 February 2025 in Nano Letters
Verified
Journal Article
Closed access
SPStanislav Piletsky
Stanislav Piletsky
EKErin E. Keblish
Erin E. Keblish
DHDaniel A. Heller
Daniel A. Heller

30 October 2023 in Nano Letters
Verified
Journal Article
Open access
SPStanislav Piletsky
Stanislav Piletsky
EBEkaterina Baidyuk
Ekaterina Baidyuk
Elena PiletskaElena Piletska
Elena Piletska
LLLarissa Lezina
Larissa Lezina
KSKonstantin Shevchenko
Konstantin Shevchenko
Nick BarlevNick Barlev
Nick Barlev
In recent years, molecularly imprinted polymer nanoparticles (nanoMIPs) have proven to be an attractive alternative to antibodies in diagnostic and therapeutic applications. However, several key questions remain: how suitable are intracellular epitopes as targets for nanoMIP binding? And to what extent can protein function be modulated via targeting specific epitopes? To investigate this, three extracellular and three intracellular epitopes of epidermal growth factor receptor (EGFR) were used as templates for the synthesis of nanoMIPs which were then used to treat cancer cells with different expression levels of EGFR. It was observed that nanoMIPs imprinted with epitopes from the intracellular kinase domain and the extracellular ligand binding domain of EGFR caused cells to form large foci of EGFR sequestered away from the cell surface, caused a reduction in autophosphorylation, and demonstrated effects on cell viability. Collectively, this suggests that intracellular domain-targeting nanoMIPs can be a potential new tool for cancer therapy.